\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ proptosis\\ and\\ erythema\\ on\\ right\\.\ \(0\)\
\-\ antibiotics\\ and\\ steroids\\ with\\ resolution\\ of\\ symptoms\\ anticipated\\ in\\ 48\\ hours\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mild\\ proptosis\ \(0\)\
\-\ \\â\\€\\¢\\ diffuse\\ enlargement\\ of\\ the\\ right\\ medial\\ rectus\\ muscle\ \(0\)\
\-\ \\â\\€\\¢\\ the\\ tendon\\ of\\ the\\ muscle\\ is\\ also\\ enlarged\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ abscess\\ noted\ \(0\)\
\-\ orbital\\ \\ pseudotumor\ \(0\)\
\-\ \\â\\€\\¢\\ thyroid\\ ophthalmopathy\\ \\(graves\\ disease\\)\ \(0\)\
\-\ \\â\\€\\¢\\ orbital\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ orbital\\ cellulitis\ \(0\)\
\-\ \\â\\€\\¢\\ pseudotumor\\,\\ tolosa\\-hunt\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\\ \\(usually\\ painless\\)\ \(0\)\
\-\ \\â\\€\\¢\\ wegener\\'s\\ granulomatosis\ \(0\)\
\-\ 27\\ year\\ old\\ woman\\ with\\ 10\\ days\\ of\\ right\\ orbital\\ pain\\.\ \(1\)\
\-\ progressive\\ proptosis\\ and\\ limitation\\ of\\ eye\\ movement\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ orbital\\:\\ 0\\.44281073193038467\ \(0\)\
\-\ proptosis\\:\\ 0\\.3820051661779834\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.2621317084992981\ \(0\)\
\-\ muscle\\:\\ 0\\.17923457612806534\ \(0\)\
\-\ anticipated\\:\\ 0\\.17116496364747613\ \(0\)\
\-\ abscess\\:\\ 0\\.16208576257522686\ \(0\)\
\-\ ophthalmopathy\\:\\ 0\\.15878339350296278\ \(0\)\
\-\ limitation\\:\\ 0\\.15448766710709266\ \(0\)\
\-\ mild\\:\\ 0\\.14308946323977775\ \(0\)\
\-\ wegener\\:\\ 0\\.14119546939885136\ \(0\)\
\-\ graves\\:\\ 0\\.13915169799829227\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.13915169799829227\ \(0\)\
\-\ cellulitis\\:\\ 0\\.13246369544524195\ \(0\)\
\-\ rectus\\:\\ 0\\.1306188667929803\ \(0\)\
\-\ right\\:\\ 0\\.12553128466337107\ \(0\)\
\-\ of\\:\\ 0\\.12349346904644298\ \(0\)\
\-\ painless\\:\\ 0\\.11688853344918472\ \(0\)\
\-\ movement\\:\\ 0\\.11618608948020877\ \(0\)\
\-\ erythema\\:\\ 0\\.11420340912604823\ \(0\)\
\-\ steroids\\:\\ 0\\.1108832972638035\ \(0\)\
\-\ tendon\\:\\ 0\\.11016952160362951\ \(0\)\
\-\ 48\\:\\ 0\\.10930851309317292\ \(0\)\
\-\ resolution\\:\\ 0\\.10240130339779976\ \(0\)\
\-\ 27\\:\\ 0\\.10227804332089493\ \(0\)\
\-\ eye\\:\\ 0\\.1009656565429876\ \(0\)\
\-\ thyroid\\:\\ 0\\.09918579265470906\ \(0\)\
\-\ enlargement\\:\\ 0\\.09675869022466765\ \(0\)\
\-\ progressive\\:\\ 0\\.09666311717506042\ \(0\)\
\-\ hours\\:\\ 0\\.09619134820151606\ \(0\)\
\-\ antibiotics\\:\\ 0\\.09298170110752028\ \(0\)\
\-\ enlarged\\:\\ 0\\.08603888241606576\ \(0\)\
\-\ medial\\:\\ 0\\.08215298960317882\ \(0\)\
\-\ days\\:\\ 0\\.07989624510106683\ \(0\)\
\-\ usually\\:\\ 0\\.07945372781848753\ \(0\)\
\-\ diffuse\\:\\ 0\\.07914914899467392\ \(0\)\
\-\ and\\:\\ 0\\.07823911279950968\ \(0\)\
\-\ syndrome\\:\\ 0\\.0760869800823817\ \(0\)\
\-\ the\\:\\ 0\\.07555026823335687\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0751657343264931\ \(0\)\
\-\ 10\\:\\ 0\\.07380106479401714\ \(0\)\
\-\ symptoms\\:\\ 0\\.0690548380281347\ \(0\)\
\-\ noted\\:\\ 0\\.06691623647490208\ \(0\)\
\-\ woman\\:\\ 0\\.06573046207627911\ \(0\)\
\-\ also\\:\\ 0\\.059365459808345004\ \(0\)\
\-\ disease\\:\\ 0\\.05297837877739669\ \(0\)\
\-\ with\\:\\ 0\\.04942690254590854\ \(0\)\
\-\ pain\\:\\ 0\\.04516250121654749\ \(0\)\
\-\ no\\:\\ 0\\.041041981847429715\ \(0\)\
\-\ year\\:\\ 0\\.03889536696668173\ \(0\)\
\-\ on\\:\\ 0\\.038117517592520654\ \(0\)\
\-\ old\\:\\ 0\\.03735301625341949\ \(0\)\
\-\ is\\:\\ 0\\.03456340361614356\ \(0\)\
\-\ in\\:\\ 0\\.031396895323374405\ \(0\)\
